Loading market dashboard
Kiniksa Pharmaceuticals, Ltd.
KNSAHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Kiniksa Pharmaceuticals, Ltd. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.58B | $1.57B - $1.60B | -$315.82M | $4.433 | 6 |
| Dec 2029 | $1.43B | $1.41B - $1.44B | -$284.89M | $2.955 | 3 |
| Dec 2028 | $1.27B | $1.27B - $1.27B | -$253.64M | $2.496 | 7 |
| Dec 2027 | $1.13B | $1.12B - $1.14B | -$225.20M | $1.915 | 6 |
| Dec 2026 | $939.49M | $937.45M - $941.52M | -$187.82M | $1.372 | 6 |
| Dec 2025 | $676.45M | $675.21M - $677.69M | -$135.23M | $0.974 | 5 |
| Dec 2024 | $424.18M | $423.70M - $424.42M | -$84.80M | -$0.394 | 4 |
| Dec 2023 | $338.93M | $336.08M - $342.38M | -$67.76M | -$0.145 | 3 |
| Dec 2022 | $203.34M | $192.72M - $212.50M | -$135.04M | $2.38 | 1 |
| Dec 2021 | $37.40M | $35.45M - $39.08M | -$159.24M | -$2.185 | 1 |